(Q80067156)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892357%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

title

1-(1-phenethylpiperidin-4-yl)-1-phenylethanols as potent and highly selective 5-HT2A antagonists (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892357%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

author name string

Timo Heinrich

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892357%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Henning Böttcher

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892357%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Helmut Prücher

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892357%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Rudolf Gottschlich

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892357%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Karl-August Ackermann

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892357%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Christoph van Amsterdam

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892357%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

publication date

1 February 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892357%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892357%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

volume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892357%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892357%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

245-255

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892357%20AND%20SRC:MED&resulttype=core&format=json

The pharmacology of central serotonergic neural transmission systems

28 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500023

7 January 2021

Pharmacological manipulation of human working memory

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500023

7 January 2021

The role of serotonin in schizophrenia: an overview of the nomenclature, distribution and alterations of serotonin receptors in the central nervous system

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500023

7 January 2021

Classification and nomenclature of 5-HT receptors: a comment on current issues

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500023

7 January 2021

Electrophysiology of the central serotonin system: receptor subtypes and transducer mechanisms.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500023

7 January 2021

Serotonin 5-HT2 receptor activation potentiates N-methyl-D-aspartate receptor-mediated ion currents by a protein kinase C-dependent mechanism.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500023

7 January 2021

Modulation of innate immune responses in the treatment of sepsis and pneumonia

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500023

7 January 2021

Atypical antipsychotics: are some more atypical than others?

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500023

7 January 2021

Serotonin 5-HT2c agonists mimic the effect of light pulses on circadian rhythms.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500023

7 January 2021

Ritanserin improves sleep quality in narcolepsy

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500023

7 January 2021

Ritanserin, a serotonin-2 receptor antagonist, improves ultradian sleep rhythmicity in young poor sleepers

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500023

7 January 2021

Comparison of the potency of MDL 100,907 and SB 242084 in blocking the serotonin (5-HT)(2) receptor agonist-induced increases in rat serum corticosterone concentrations: evidence for 5-HT(2A) receptor mediation of the HPA axis

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500023

7 January 2021

Clozapine and other 5-hydroxytryptamine-2A receptor antagonists alter the subcellular distribution of 5-hydroxytryptamine-2A receptors in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500023

7 January 2021

The role of positron emission tomography in the drug development of M100907, a putative antipsychotic with a novel mechanism of action

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500023

7 January 2021

5-HT2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100,907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500023

7 January 2021

The anticonvulsant MK-801 is a potent N-methyl-D-aspartate antagonist

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500023

7 January 2021

The apparent antipsychotic action of the 5-HT2a receptor antagonist M100907 in a mouse model of schizophrenia is counteracted by ritanserin. (Rapid communication)

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500023

7 January 2021

Current and novel approaches to the drug treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500023

7 January 2021

High 5HT2A receptor occupancy in M100907-treated schizophrenic patients

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500023

7 January 2021

Pharmacological characterization of serotonergic receptor activity in the hypoglossal nucleus

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500023

7 January 2021

Pharmacological treatment strategies for schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500023

7 January 2021

5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: interactions with global 5-HT depletion

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500023

7 January 2021

[3H]MDL 100,907: a novel selective 5-HT2A receptor ligand

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500023

7 January 2021

Synthesis and phosphodiesterase 5 inhibitory activity of novel phenyl ring modified sildenafil analogues

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500023

7 January 2021

Synthesis and neuroleptic activity of 3-(1-substituted-4-piperidinyl)-1,2-benzisoxazoles.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500023

7 January 2021

Indolebutylamines as selective 5-HT(1A) agonists

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500023

7 January 2021

Synthesis and structure--activity relationship in a class of indolebutylpiperazines as dual 5-HT(1A) receptor agonists and serotonin reuptake inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500023

7 January 2021

EMD 281014, a new selective serotonin 5-HT2A receptor antagonist

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500023

7 January 2021

EMD 281014, a specific and potent 5HT2 antagonist in humans: a dose-finding PET study

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500023

7 January 2021

Investigation of the CNS penetration of a potent 5-HT2a receptor antagonist (MDL 100,907) and an active metabolite (MDL 105,725) using in vivo microdialysis sampling in the rat.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500023

7 January 2021

The binding of serotonergic ligands to the porcine choroid plexus: characterization of a new type of serotonin recognition site

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500023

7 January 2021

The pharmacology and distribution of human 5‐hydroxytryptamine2B (5‐HT2b) receptor gene products: comparison with 5‐HT2a and 5‐HT2c receptors

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200500023

7 January 2021

Identifiers

DOI

10.1002/CMDC.200500023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892357%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference